These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18084878)

  • 1. New approaches to the treatment of AIDS with special reference to overcoming interferon resistance.
    Ambrus JL; Ambrus JL; Bardos TJ; Dembinski W; Chadha KC
    J Med; 2004; 35(1-6):201-9. PubMed ID: 18084878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evaluation of mismatched double-stranded RNA (ampligen) for combination therapy in the treatment of acquired immunodeficiency syndrome.
    Montefiori DC; Robinson WE; Mitchell WM
    AIDS Res Hum Retroviruses; 1989 Apr; 5(2):193-203. PubMed ID: 2469450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal regulatory protein alpha negatively regulates both TLR3 and cytoplasmic pathways in type I interferon induction.
    Dong LW; Kong XN; Yan HX; Yu LX; Chen L; Yang W; Liu Q; Huang DD; Wu MC; Wang HY
    Mol Immunol; 2008 Jun; 45(11):3025-35. PubMed ID: 18471880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferons and interferon inhibitory activity in disease and therapy.
    Chadha KC; Ambrus JL; Dembinski W; Ambrus JL
    Exp Biol Med (Maywood); 2004 Apr; 229(4):285-90. PubMed ID: 15044711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of increasing thiolation of the polycytidylic acid strand of poly I:poly C on the alpha, beta and gamma interferon-inducing properties, antiviral and antiproliferative activities.
    Chadha KC; Dembinski WE; Dunn CB; Aradi J; Bardos TJ; Dunn JA; Ambrus JL
    Antiviral Res; 2004 Dec; 64(3):171-7. PubMed ID: 15550270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review. Drug resistance of human immunodeficiency virus and overcoming it by natural products.
    Hupfeld J; Efferth T
    In Vivo; 2009; 23(1):1-6. PubMed ID: 19368117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reduction of voluntary physical activity after poly I:C injection is independent of the effect of poly I:C-induced interferon-beta in mice.
    Matsumoto T; Takahashi H; Shiva D; Kawanishi N; Kremenik MJ; Kato Y; Yano H
    Physiol Behav; 2008 Mar; 93(4-5):835-41. PubMed ID: 18191426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New "ThetaSwitch" drug may increase long-term survival in HIV disease.
    J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):59. PubMed ID: 11363523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
    Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL
    Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR3: interferon induction by double-stranded RNA including poly(I:C).
    Matsumoto M; Seya T
    Adv Drug Deliv Rev; 2008 Apr; 60(7):805-12. PubMed ID: 18262679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classical swine fever virus Erns glycoprotein antagonizes induction of interferon-beta by double-stranded RNA.
    Luo X; Ling D; Li T; Wan C; Zhang C; Pan Z
    Can J Microbiol; 2009 Jun; 55(6):698-704. PubMed ID: 19767841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research on the selective kinetics of HIV-1 nucleoside reverse transcriptase inhibitor drug resistance-associated mutations among 4 AIDS patients receiving highly active antiretroviral therapy].
    Li J; Jiao LY; Li HP; Li L; Liu YJ; Zhuang DM; Liu SY; Bao ZY; Li H; Wang Z; Li JY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Aug; 29(8):794-800. PubMed ID: 19103117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cigarette smoke attenuation of poly I:C-induced innate antiviral responses in human PBMC is mainly due to inhibition of IFN-beta production.
    Mian MF; Stämpfli MR; Mossman KL; Ashkar AA
    Mol Immunol; 2009 Feb; 46(5):821-9. PubMed ID: 18930547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Special considerations and treatment of patients with HBV-HIV coinfection.
    Dieterich DT
    Antivir Ther; 2007; 12 Suppl 3():H43-51. PubMed ID: 18284182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
    Hofmann WP; Soriano V; Zeuzem S
    Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral drug discovery: ten more compounds, and ten more stories (part B).
    De Clercq E
    Med Res Rev; 2009 Jul; 29(4):571-610. PubMed ID: 19219846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the nonstructural protein 4B of hepatitis C virus as a factor that inhibits the antiviral activity of interferon-alpha.
    Xu J; Liu S; Xu Y; Tien P; Gao G
    Virus Res; 2009 Apr; 141(1):55-62. PubMed ID: 19185598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel interferons for treatment of hepatitis C virus.
    Clark V; Nelson DR
    Clin Liver Dis; 2009 Aug; 13(3):351-63. PubMed ID: 19628153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of HIV infections and AIDS: new horizons.
    Koech DK; Obel AO
    East Afr Med J; 1990 Jul; 67(7 Suppl 2):SS77-81. PubMed ID: 2226236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-stranded polyinosinic acid oligonucleotides trigger leukocyte production of proteins belonging to fibrinolytic and coagulation cascades.
    Zare F; Magnusson M; Möllers LN; Jin T; Tarkowski A; Bokarewa M
    J Leukoc Biol; 2008 Sep; 84(3):741-7. PubMed ID: 18562486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.